Effect of low-dose bortezomib on bone formation in smouldering multiple myeloma

Br J Haematol. 2019 Jan;184(2):308-310. doi: 10.1111/bjh.15095. Epub 2018 Mar 24.

Authors

Gerhard C Hildebrandt¹, Tamara Berno², Andrea Gurule³, Meera Mohan², Doonghoon Yoon², Mohamed Salama⁴, Maurizio Zangari²

Affiliations

¹ Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
² Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
³ Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
⁴ Department of Pathology, University of Utah, Salt Lake City, UT, USA.

PMID: 29574687
DOI: 10.1111/bjh.15095

No abstract available

Keywords: DEXA scan; bone anabolic effects; bone mineral density; bortezomib; smouldering myeloma.

Publication types

Letter

MeSH terms

Adult
Aged
Bortezomib / administration & dosage*
Female
Humans
Male
Middle Aged
Multiple Myeloma* / drug therapy
Multiple Myeloma* / metabolism
Multiple Myeloma* / pathology
Osteogenesis / drug effects*
Smoldering Multiple Myeloma* / drug therapy
Smoldering Multiple Myeloma* / metabolism
Smoldering Multiple Myeloma* / pathology

Substances

Bortezomib